BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21943982)

  • 1. 2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapy.
    Gridelli C; Rossi A; Maione P
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S248-57. PubMed ID: 21943982
    [No Abstract]   [Full Text] [Related]  

  • 2. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment.
    Planchard D; Le PĂ©choux C
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S272-83. PubMed ID: 21943984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection.
    Gomperts BN; Spira A; Elashoff DE; Dubinett SM
    Cancer Prev Res (Phila); 2010 Apr; 3(4):420-3. PubMed ID: 20332300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and early detection of lung cancer.
    Van't Westeinde SC; van Klaveren RJ
    Cancer J; 2011; 17(1):3-10. PubMed ID: 21263260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current standards and new trends in the primary treatment of colorectal cancer.
    Stein A; Atanackovic D; Bokemeyer C
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S312-4. PubMed ID: 21943995
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA in lung cancer diagnostics and treatment.
    Skrzypski M; Dziadziuszko R; Jassem J
    Mutat Res; 2011 Dec; 717(1-2):25-31. PubMed ID: 21540042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges in lung cancer early detection biomarkers.
    Montuenga LM; Pio R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():377-8. PubMed ID: 19775637
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels.
    Schneider J
    Cancer Biomark; 2010; 6(3-4):149-62. PubMed ID: 20660961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of novel combinations of biomarkers for the detection of colorectal cancer.
    Shimwell NJ; Wei W; Wilson S; Wakelam MJ; Ismail T; Iqbal T; Johnson PJ; Martin A; Ward DG
    Cancer Biomark; 2010; 7(3):123-32. PubMed ID: 21263188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Guidelines for the Management of Lung Cancer and evaluation from clinical practice].
    Morikawa T
    Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):237-41. PubMed ID: 17907451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer screening.
    van Klaveren RJ
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S147-55. PubMed ID: 21943968
    [No Abstract]   [Full Text] [Related]  

  • 14. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological markers in lung cancer: A clinician's perspective.
    Tufman A; Huber RM
    Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current views in primary pulmonary cancer.
    Martini N; Beattie EJ
    Int Adv Surg Oncol; 1980; 3():275-97. PubMed ID: 6256294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection and screening of lung cancer.
    Mascaux C; Peled N; Garg K; Kato Y; Wynes MW; Hirsch FR
    Expert Rev Mol Diagn; 2010 Sep; 10(6):799-815. PubMed ID: 20843203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.